Cargando…

Intrinsic PD‐L1 promotes antitumor activity of CD8(+) cytotoxic T lymphocytes via in cis interaction with CD80

Detalles Bibliográficos
Autores principales:	Ding, Yuming, Chen, Chaojia, Ma, Shuaiya, Sheng, Xue, Zhao, Fangcheng, Peng, Jiali, Dong, Haoqing, Ma, Chunhong, Li, Chunyang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395321/ https://www.ncbi.nlm.nih.gov/pubmed/35866993 http://dx.doi.org/10.1002/cac2.12337

Ejemplares similares

Blockade of trans PD-L1 interaction with CD80 augments antitumor immunity
por: Zhang, Yuankun, et al.
Publicado: (2023)

ADAP and SKAP55 deficiency suppresses PD-1 expression in CD8(+) cytotoxic T lymphocytes for enhanced anti-tumor immunotherapy
por: Li, Chunyang, et al.
Publicado: (2015)

By Binding CD80 and CD86, the Vaccinia Virus M2 Protein Blocks Their Interactions with both CD28 and CTLA4 and Potentiates CD80 Binding to PD-L1
por: Kleinpeter, Patricia, et al.
Publicado: (2019)

CD80 Expressed by CD8(+) T Cells Contributes to PD-L1-Induced Apoptosis of Activated CD8(+) T Cells
por: Rollins, Meagan R., et al.
Publicado: (2017)

Chimeric CTLA4-CD28-CD3z T Cells Potentiate Antitumor Activity Against CD80/CD86–Positive B Cell Malignancies
por: Lin, Shouheng, et al.
Publicado: (2021)

Increased CD86 but Not CD80 and PD-L1 Expression on Liver CD68(+) Cells during Chronic HBV Infection
por: Said, Elias A., et al.
Publicado: (2016)

Low Dose Decitabine Treatment Induces CD80 Expression in Cancer Cells and Stimulates Tumor Specific Cytotoxic T Lymphocyte Responses
por: Wang, Li-Xin, et al.
Publicado: (2013)

Regulation of GVHD and GVL Activity via PD-L1 Interaction With PD-1 and CD80
por: Cassady, Kaniel, et al.
Publicado: (2018)

Conditional Deletion of Pdcd1 Identifies the Cell-Intrinsic Action of PD-1 on Functional CD8 T Cell Subsets for Antitumor Efficacy
por: Raghavan, Sukanya, et al.
Publicado: (2021)

Dendritic cell subsets require cis-activation for cytotoxic CD8 T cell induction
por: Desch, A. Nicole, et al.
Publicado: (2014)

Embryonic Fibroblasts Promote Antitumor Cytotoxic Effects of CD8(+) T Cells
por: Qin, Yingyu, et al.
Publicado: (2018)

Role of CD8 in Aberrant Function of Cytotoxic T Lymphocytes
por: Kessler, Benedikt, et al.
Publicado: (1997)

CRTAM determines the CD4(+) cytotoxic T lymphocyte lineage
por: Takeuchi, Arata, et al.
Publicado: (2016)

Prevalence of CD8(+) cytotoxic lymphocytes in human neoplasms
por: Blessin, Niclas C., et al.
Publicado: (2020)

Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25(+) Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses
por: Sutmuller, Roger P.M., et al.
Publicado: (2001)

Cd40-Independent Pathways of T Cell Help for Priming of Cd8(+) Cytotoxic T Lymphocytes
por: Lu, Zhengbin, et al.
Publicado: (2000)

Immunolocalization of CD80 and CD86 in Non-Small Cell Lung Carcinoma: CD80 as a Potent Prognostic Factor
por: Sato, Takashi, et al.
Publicado: (2022)

Soluble CD80 oral delivery by recombinant Lactococcus suppresses tumor growth by enhancing antitumor immunity
por: Lin, Ziqing, et al.
Publicado: (2023)

Suppression of Tumor or Host Intrinsic CMTM6 Drives Antitumor Cytotoxicity in a PD-L1–Independent Manner
por: Long, Yiru, et al.
Publicado: (2023)

Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating T cell receptor signaling of cytotoxic CD8 T cell
por: Zhu, Xinhai, et al.
Publicado: (2023)

Cooperative B7-1/2 (CD80/CD86) and B7-DC Costimulation of CD4(+) T Cells Independent of the PD-1 Receptor
por: Shin, Tahiro, et al.
Publicado: (2003)

CD4 T cells transduced with CD80 and 4-1BBL mRNA induce long-term CD8 T cell responses resulting in potent antitumor effects
por: Cho, Hyun-Il, et al.
Publicado: (2014)

Cytotoxic T lymphocyte-associated antigen-4-Ig (CTLA-4-Ig) suppresses Staphylococcus aureus-induced CD80, CD86, and pro-inflammatory cytokine expression in human B cells
por: Liu, Po-Chun, et al.
Publicado: (2020)

Enrichment of CD8+ CD28- cytotoxic T cells in circulating lymphocytes of patients with ankylosing spondylitis
por: Schirmer, M, et al.
Publicado: (2001)

Accumulation of CD5(+)CD19(+) B lymphocytes expressing PD-1 and PD-1L in hypertrophied pharyngeal tonsils
por: Wlasiuk, Paulina, et al.
Publicado: (2015)

Direct activation of CD8+ cytotoxic T lymphocytes by dendritic cells
Publicado: (1987)

A Potential Inhibitory Profile of Liver CD68(+) Cells during HCV Infection as Observed by an Increased CD80 and PD-L1 but Not CD86 Expression
por: Said, Elias A., et al.
Publicado: (2016)

Presence of lymphocytic infiltrate cytotoxic T lymphocyte CD3(+), CD8(+), and immunoscore as prognostic marker in patients after radical cystectomy
por: Yu, Alice, et al.
Publicado: (2018)

EOMES is essential for antitumor activity of CD8(+) T cells in chronic lymphocytic leukemia
por: Llaó-Cid, Laura, et al.
Publicado: (2021)

BRCA1 deficiency in mature CD8(+) T lymphocytes impairs antitumor immunity
por: Wu, Bogang, et al.
Publicado: (2023)

Antigen-Presenting Cell-Intrinsic PD-1 Neutralizes PD-L1 in cis to Attenuate PD-1 Signaling in T Cells
por: Zhao, Yunlong, et al.
Publicado: (2018)

Peripheral CD8+CD28+ T lymphocytes predict the efficacy and safety of PD-1/PD-L1 inhibitors in cancer patients
por: Geng, Ruixuan, et al.
Publicado: (2023)

Inefficient boosting of antitumor CD8(+) T cells by dendritic-cell vaccines is rescued by restricting T-cell cytotoxic functions
por: Zhi-Iong Ma, Joel, et al.
Publicado: (2012)

Cytotoxic Chemotherapy and CD4+ Effector T Cells: An Emerging Alliance for Durable Antitumor Effects
por: Ding, Zhi-Chun, et al.
Publicado: (2012)

Significance of CD80 as a Prognostic and Immunotherapeutic Biomarker in Lung Adenocarcinoma
por: Feng, Wei, et al.
Publicado: (2023)

Successful Induction of Tumor‐specific Cytotoxic T Lymphocytes from Patients with Non‐small Cell Lung Cancer Using CD80‐transfected Autologous Tumor Cells
por: Takenoyama, Mitsuhiro, et al.
Publicado: (2001)

Analysis of cytotoxic activity of the CD4+ T lymphocytes generated by local immunotherapy.
por: Katsumoto, Y., et al.
Publicado: (1996)

Delivery of Exogenous Antigens to Induce Cytotoxic CD8+ T Lymphocyte Responses
por: Kim, Julia, et al.
Publicado: (2010)

Pattern of CD4 T-lymphocyte Values in Cancer Patients on Cytotoxic Therapy
por: Madu, AJ, et al.
Publicado: (2013)

Direct Activation of Human CD8(+) Cytotoxic T Lymphocytes by Interleukin‐18
por: Kohyama, Masako, et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_6g6nj47r655g3ng3m1guo5vjsh